Generex Biotechnology Corporation (GNBT)

Recent filings

Preliminary Proxy Soliciting materials - Aug. 8, 2017

Generex Biotechnology: In Combination With Ae37 In Patients With Triple-Negative Breast Cancer - Aug. 1, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 9 - Net (Loss)... - June 15, 2017

Departure of Directors or Certain - May 26, 2017

Termination of a Material Definitive - May 22, 2017

Entry into a Material Definitive - April 27, 2017

Other preliminary proxy statements - April 18, 2017

Symbol Change - April 10, 2017

Financial Statements and - March 31, 2017

Generex Biotechnology: Generex Announces $115M Convertible Preferred Stock Financing; First Tranche Satisfies Emmaus Deposit - March 29, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 7 - Net (Loss)... - March 22, 2017

Generex Biotechnology: Generex Announces Reverse Stock Split - March 17, 2017

Notification of inability to timely file Form 10-Q or 10-QSB - March 17, 2017

Deleted Symbol - March 14, 2017

Entry into a Material Definitive - March 6, 2017

Entry into a Material Definitive - Feb. 24, 2017

Statement of acquisition of beneficial ownership by individuals - Feb. 16, 2017

Generex Biotechnology: Generex Announces Elimination Of Outstanding Derivative Securities - Feb. 15, 2017

Financial Statements and - Jan. 25, 2017

Entry into a Material Definitive - Jan. 20, 2017

Entry into a Material Definitive - Jan. 20, 2017

Generex Biotechnology: Securities And Exchange Commission - Jan. 20, 2017

Tier Change - Jan. 19, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 6 – Net (Loss)... - Jan. 18, 2017

Generex Biotechnology Corporation Just Filed Its Annual Report: Net Loss per Common... - Jan. 17, 2017

Tier Change - Jan. 14, 2017

Generex Biotechnology: Securities And Exchange Commission - Jan. 13, 2017

Tier Change - July 23, 2016

Generex Biotechnology Corporation's President & CEO just picked up 14,890,033 shares - Feb. 12, 2016

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 6 – Net (Loss)... - Jan. 14, 2016

OTCQB Certification - Dec. 1, 2015

Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine - Oct. 15, 2015

Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine - Oct. 15, 2015

Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd. - Oct. 13, 2015

Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd. - Oct. 13, 2015

Generex Biotechnology Corporation Just Filed Its Annual Report: Net Loss per Common... - Oct. 9, 2015

Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd. - Oct. 6, 2015

Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd. - Oct. 6, 2015

Generex Announces Issuance of Buccal Cannabis White Paper - Oct. 1, 2015

Generex Announces Issuance of Buccal Cannabis White Paper - Oct. 1, 2015

Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems - Sept. 30, 2015

Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems - Sept. 30, 2015

Generex Announces Commencement of Buccal Leuprolide R&D Work - Sept. 8, 2015

Generex Announces Commencement of Buccal Leuprolide R&D Work - Sept. 8, 2015

Generex Announces Formalization of Buccal Cannabis Co-Development Plan - Sept. 2, 2015

Generex Announces Formalization of Buccal Cannabis Co-Development Plan - Sept. 2, 2015

Generex Announces Issuance of Buccal Insulin White Paper - Aug. 27, 2015

Generex Announces Issuance of Buccal Insulin White Paper - Aug. 27, 2015

Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project - Aug. 25, 2015

Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project - Aug. 25, 2015

Generex Biotechnology: Securities And Exchange Commission - Aug. 20, 2015

Generex Biotechnology Corporation just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 4, 2015

Generex Biotechnology Corporation Just Received a Notice of Effectiveness - July 31, 2015

General form for registration of securities under the Securities Act of 1933 - July 17, 2015

General form for registration of securities under the Securities Act of 1933 - July 17, 2015

Revised definitive proxy soliciting materials - July 14, 2015

Other definitive proxy statements - July 7, 2015

Preliminary Proxy Soliciting materials - June 25, 2015

Generex Biotechnology: Generex Announces Capital Investment - June 25, 2015

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 6 – Net Income... - June 5, 2015

Other preliminary proxy statements - June 2, 2015

Generex Biotechnology Corporation director just picked up 5,874,162 shares - April 27, 2015

Generex Biotechnology: Item 5.02. Departure Of Directors And Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers - April 7, 2015

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 7 – Net Income... - March 6, 2015

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 7 – Net Income... - Dec. 12, 2014

Annual report [Section 13 and 15(d), not S-K Item 405] - Oct. 17, 2014

Generex Biotechnology Corporation's President & CEO just picked up 470,726 shares - Oct. 8, 2014

Generex Biotechnology Corporation director just picked up 35,714 shares - Oct. 8, 2014

Generex Biotechnology Corporation director just picked up 35,714 shares - Oct. 8, 2014

Securities to be offered to employees in employee benefit plans - July 3, 2014

Quarterly report [Sections 13 or 15(d)] - June 6, 2014

Generex Biotechnology: Submission Of Matters To A Vote Of Security Holders - May 23, 2014

[Paper] - May 6, 2014

Revised definitive proxy soliciting materials - May 5, 2014

Generex Biotechnology Corporation just filed a prospectus, suggesting it plans to soon issue some securities - April 17, 2014

Generex Biotechnology Corporation Just Received a Notice of Effectiveness - April 16, 2014

Other definitive proxy statements - April 1, 2014

Generex Biotechnology: Generex Announces $2,075,000 Capital Investment - March 28, 2014

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 8 – Net Loss Pe... - March 7, 2014

Other preliminary proxy statements - March 4, 2014

Generex Biotechnology Corporation just filed a General Statement of acquisition of beneficial ownership - Feb. 14, 2014

Generex Biotechnology Corporation just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 7, 2014

Generex Biotechnology Corporation Just Received a Notice of Effectiveness - Feb. 7, 2014

General form for registration of securities under the Securities Act of 1933 - Jan. 24, 2014

Current report, item 3.02 - Jan. 10, 2014

Quarterly report [Sections 13 or 15(d)] - Dec. 9, 2013

Current report, items 5.02 and 9.01 - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Statement of changes in beneficial ownership of securities - Nov. 1, 2013

Annual report [Section 13 and 15(d), not S-K Item 405] - Oct. 18, 2013

Prospectus [Rule 424(b)(3)] - July 25, 2013

Notice of Effectiveness - July 24, 2013

[Amend] - July 3, 2013

Statement of changes in beneficial ownership of securities - June 20, 2013

Current report, items 1.01, 3.02, 5.03, and 9.01 - June 18, 2013

Sorry, no schedule available for this company

No known shareholders

Generex Biotechnology Corporation (GNBT)

140

cctranscripts

Aug. 8, 2017

Preliminary Proxy Soliciting materials http://www.conferencecalltranscripts.org/pink/summary?id=4031517

cctranscripts

Aug. 1, 2017

Generex Biotechnology: In Combination With Ae37 In Patients With Triple-Negative Breast Cancer http://www.conferencecalltranscripts.org/pink/summary?id=4007924

cctranscripts

June 15, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 9 - Net (Loss)... http://www.conferencecalltranscripts.org/pink/summary?id=3890542

cctranscripts

May 26, 2017

Departure of Directors or Certain http://www.conferencecalltranscripts.org/pink/summary?id=3834507

cctranscripts

May 22, 2017

Termination of a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=3816598

cctranscripts

April 27, 2017

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=3730264

cctranscripts

April 18, 2017

Other preliminary proxy statements http://www.conferencecalltranscripts.org/pink/summary?id=3697429

cctranscripts

April 10, 2017

Symbol Change http://www.otcmarkets.com/market-activity/corpActions.jsp?index=1&symbol=GNBTD&actionDate=1491800406000

cctranscripts

March 31, 2017

Financial Statements and http://www.conferencecalltranscripts.org/pink/summary?id=3648730

cctranscripts

March 29, 2017

Generex Biotechnology: Generex Announces $115M Convertible Preferred Stock Financing; First Tranche Satisfies Emmaus Deposit http://www.conferencecalltranscripts.org/pink/summary?id=3637897

cctranscripts

March 22, 2017

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 7 - Net (Loss)... http://www.conferencecalltranscripts.org/pink/summary?id=3615508

cctranscripts

March 17, 2017

Generex Biotechnology: Generex Announces Reverse Stock Split http://www.conferencecalltranscripts.org/pink/summary?id=3602336

cctranscripts

March 17, 2017

Notification of inability to timely file Form 10-Q or 10-QSB http://www.conferencecalltranscripts.org/pink/summary?id=3602229

cctranscripts

March 14, 2017

Deleted Symbol http://www.otcmarkets.com/market-activity/corpActions.jsp?index=5&symbol=GNBT&actionDate=1489467609000

cctranscripts

March 6, 2017

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=3563015

cctranscripts

Feb. 24, 2017

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=3528924

cctranscripts

Feb. 16, 2017

Statement of acquisition of beneficial ownership by individuals http://www.conferencecalltranscripts.org/pink/summary?id=3501244

cctranscripts

Feb. 15, 2017

Generex Biotechnology: Generex Announces Elimination Of Outstanding Derivative Securities http://www.conferencecalltranscripts.org/pink/summary?id=3496809

cctranscripts

Jan. 25, 2017

Financial Statements and http://www.conferencecalltranscripts.org/pink/summary?id=3414579

cctranscripts

Jan. 20, 2017

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=3403763
 


Feedback